Awarded contract

NHS National Framework for Natalizumab-February 2024

Details

Buyer: NHS England
Supplier(s): Samsung Bioepis UK Ltd, Alexion Pharmaceuticals, Amgen Ltd
Value: GBP 3
Topic: Pharmaceutical products
Published: 2 February 2024
Source: uk:find_a_tender

Tender description

Project Title: NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024<br/>Offer reference number: CM/PHR/22/5693<br/>Period of framework: 1 February 2024 to 30 April 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Lot 1: Project Title: NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024<br/>Offer reference number: CM/PHR/22/5693<br/>Period of framework: 1 February 2024 to 30 April 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

Timeline

Completed: Award date5 January 2024
Completed: Award published2 February 2024
Current notice

About the buyer

NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

33600000 · Pharmaceutical products

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@nhs-england.gov
Commercial Director	+44 •••• ••••••	••••••••@nhs-england.gov
Procurement Manager	+44 •••• ••••••	••••••••@nhs-england.gov
Category Lead	+44 •••• ••••••	••••••••@nhs-england.gov
Senior Buyer	+44 •••• ••••••	••••••••@nhs-england.gov
Contracts Manager	+44 •••• ••••••	••••••••@nhs-england.gov